1. Vyas, Hrushikesh, Alcheikh, Ahmad, Lowe, Gillian, Morgan, Neil V, Rabbolini, David J. 2022. Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases. In Platelets, 33, 1107-1112. doi:10.1080/09537104.2022.2071853. https://pubmed.ncbi.nlm.nih.gov/35587581/
2. Fayiga, Folasade F, Reyes-Hadsall, Sophia C, Moreno, Brian A, Brathwaite, Carole, Duarte, Ana M. 2023. Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review. In Journal of cutaneous pathology, 50, 425-429. doi:10.1111/cup.14404. https://pubmed.ncbi.nlm.nih.gov/36753059/
3. Staubitz, Julia Isabelle, Musholt, Thomas Johannes, Schad, Arno, Roth, Wilfried, Hartmann, Nils. 2019. ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma. In Cancer genetics, 238, 10-17. doi:10.1016/j.cancergen.2019.07.002. https://pubmed.ncbi.nlm.nih.gov/31425920/
4. Sullivan, Mia J, Palmer, Elizabeth L, Botero, Juliana Perez. 2022. ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms. In Current hematologic malignancy reports, 17, 105-112. doi:10.1007/s11899-022-00666-4. https://pubmed.ncbi.nlm.nih.gov/35751752/
5. Desiderio, Antonella, Longo, Michele, Parrillo, Luca, Beguinot, Francesco, Raciti, Gregory A. 2019. Epigenetic silencing of the ANKRD26 gene correlates to the pro-inflammatory profile and increased cardio-metabolic risk factors in human obesity. In Clinical epigenetics, 11, 181. doi:10.1186/s13148-019-0768-0. https://pubmed.ncbi.nlm.nih.gov/31801613/